GCM
ELV icon

Gallacher Capital Management’s Elevance Health ELV Stock Holding History

Gallacher Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-490
Closed -$214K – 271
2023
Q3 		$214K Buy
+490
New +$222K 0.13% 211

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Gallacher Capital Management's ELV Position: Q4 2023 in Review

Gallacher Capital Management sold out of Elevance Health (ELV) in Q4 2023, closing a stake of 490 shares — an estimated $214K sold.

Gallacher Capital Management first reported a position in ELV in Q3 2023 and held it in 1 quarter. The position peaked at $214K in Q3 2023. 1,655 funds tracked by Wall St. Rank hold ELV as of Q4 2023.

  • Gallacher Capital Management reported no remaining Elevance Health position as of Q4 2023 after selling out during the quarter.
  • Gallacher Capital Management sold 490 Elevance Health shares in Q4 2023, an estimated $214K.
  • Gallacher Capital Management first reported a position in Elevance Health in Q3 2023 and held it in 1 quarter.
  • Gallacher Capital Management's Elevance Health position peaked at $214K in Q3 2023.
  • 1,655 funds tracked by Wall St. Rank held Elevance Health as of Q4 2023.

Based on Gallacher Capital Management's 13F filing for Q4 2023, filed 6 Feb 2024.